{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:58:09Z","timestamp":1770523089778,"version":"3.49.0"},"reference-count":27,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,1,29]]},"DOI":"10.1248\/bpb.b24-00582","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T22:11:44Z","timestamp":1738102304000},"page":"51-59","source":"Crossref","is-referenced-by-count":1,"title":["An Underlying Mechanism for the Altered Hypoglycemic Effects of Nateglinide in Rats with Acute Peripheral Inflammation"],"prefix":"10.1248","volume":"48","author":[{"given":"Haruka","family":"Toko","sequence":"first","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Ogino","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Nishiwaki","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moeko","family":"Kojina","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Aiba","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. <i>Intensive Care Med<\/i>., <b>28<\/b>, 936\u2013942 (2002).","DOI":"10.1007\/s00134-002-1313-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Llopis-Salvia P, Jim\u00e9nez-Torres NV. Population pharmacokinetic parameters of vancomycin in critically ill patients. <i>J. Clin. Pharm. Ther<\/i>., <b>31<\/b>, 447\u2013454 (2006).","DOI":"10.1111\/j.1365-2710.2006.00762.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. <i>Crit. Care Med<\/i>., <b>37<\/b>, 840\u2013851, quiz, 859 (2009).","DOI":"10.1097\/CCM.0b013e3181961bff"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Harvey RD, Morgan ET. Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents. <i>Clin. Pharmacol. Ther<\/i>., <b>96<\/b>, 449\u2013457 (2014).","DOI":"10.1038\/clpt.2014.143"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Schmitt C, Kuhn B, Zhang X, Kivitz AJ, Grange S. Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis. <i>Clin. Pharmacol. Ther<\/i>., <b>89<\/b>, 735\u2013740 (2011).","DOI":"10.1038\/clpt.2011.35"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Trousil S, Lee P, Edwards RJ, Maslen L, Lozan-Kuehne JP, Ramaswami R, Aboagye EO, Clarke S, Liddle C, Sharma R. Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumor-associated inflammation. <i>Br. J. Pharmacol<\/i>., <b>176<\/b>, 3712\u20133722 (2019).","DOI":"10.1111\/bph.14776"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre J-M, Maurel P, Vilarem M-J, Pascussi JM. Interleukin 1\u03b2 inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. <i>Hepatology<\/i>, <b>40<\/b>, 951\u2013960 (2004).","DOI":"10.1002\/hep.1840400426"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y. Role of NF-\u03baB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. <i>J. Biol. Chem<\/i>., <b>281<\/b>, 17882\u201317889 (2006).","DOI":"10.1074\/jbc.M601302200"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lopes AH, Silva RL, Fonseca MD, Gomes FI, Maganin AG, Ribeiro LS, Marques LMM, Cunha FQ, Alves-Filho JC, Zamboni DS, Lopes NP, Franklin BS, Gombault A, Ramalho FS, Quesniaux VFJ, Couillin I, Ryffel B, Cunha TM. Molecular basis of carrageenan-induced cytokines production in macrophages. <i>Cell Commun. Signal<\/i>., <b>18<\/b>, 141 (2020).","DOI":"10.1186\/s12964-020-00621-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Iber H, Chen Q, Cheng PY, Morgan ET. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-\u03baB binding at the transcription start site. <i>Arch. Biochem. Biophys<\/i>., <b>377<\/b>, 187\u2013194 (2000).","DOI":"10.1006\/abbi.2000.1772"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. <i>Endocr. Rev<\/i>., <b>23<\/b>, 687\u2013702 (2002).","DOI":"10.1210\/er.2001-0038"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kojina M, Suzuki K, Nishiwaki A, Aiba T. Acute peripheral inflammation increases plasma concentration of hypoglycemic agent nateglinide with decreased hepatic drug-metabolizing activity in rats. <i>Biol. Pharm. Bull<\/i>., <b>44<\/b>, 96\u2013102 (2021).","DOI":"10.1248\/bpb.b20-00677"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kajikawa N, Doi M, Kusaba J-I, Aiba T. Effect of carrageenan-induced acute peripheral inflammation on the pharmacokinetics and hepatic metabolism of midazolam in rats. <i>Drug Metab. Pharmacokinet<\/i>., <b>29<\/b>, 400\u2013406 (2014).","DOI":"10.2133\/dmpk.DMPK-14-RG-020"},{"key":"14","unstructured":"14) Jusko WJ. Chapter 2: Guidelines for collection and analysis of pharmacokinetic data. <i>Applied Pharmacokinetics &amp; Pharmacodynamics 4\/e<\/i>. (Burton ME, Shaw LM, Schentag JJ, Evans WE eds.), Lippincott Williams &amp; Wilkins, Philadelphia, pp. 8\u201329 (2006)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Doi M, Kajikawa N, Aiba T. Effects of dexamethasone to reverse decreased hepatic midazolam metabolism in rats with acute renal failure. <i>Xenobiotica<\/i>, <b>50<\/b>, 506\u2013514. (2020).","DOI":"10.1080\/00498254.2019.1655680"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tillmar L, Carlsson C, Welsh N. Control of insulin mRNA stability in rat pancreatic islets: regulatory role of a 3\u2032-untranslated region pyrimidine-rich sequence. <i>J. Biol. Chem<\/i>., <b>277<\/b>, 1099\u20131106 (2002).","DOI":"10.1074\/jbc.M108340200"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Chen M, Dong Y, Simard JM. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. <i>J. Neurosci<\/i>., <b>23<\/b>, 8568\u20138577 (2003).","DOI":"10.1523\/JNEUROSCI.23-24-08568.2003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Naruhashi K, Sai Y, Tamai I, Suzuki N, Tsuji A. PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine. <i>Pharm. Res<\/i>., <b>19<\/b>, 1417\u20131423 (2002).","DOI":"10.1023\/A:1020436028194"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Suzuki K, Matsumoto K, Takenaka M, Aiba T. Altered pharmacological efficacy of phenobarbital with the treatment of 7,8-dihydroxyflavone, an agonist of tropomyosin receptor kinase B, in rats. <i>Biol. Pharm. Bull<\/i>., <b>46<\/b>, 86\u201394 (2023).","DOI":"10.1248\/bpb.b22-00617"},{"key":"20","unstructured":"20) Nelson DL, Cox MM. Chapter 23: Hormonal regulation and integration of mammalian metabolism. <i>Principles of Biochemistry 7\/e<\/i>. (Nelson DL, Cox MM eds.), W. H. Freeman and Company, New York, pp. 907\u2013954 (2017)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hay CW, Docherty K. Comparative analysis of insulin gene promoters: implications for diabetes research. <i>Diabetes<\/i>, <b>55<\/b>, 3201\u20133213 (2006).","DOI":"10.2337\/db06-0788"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) McKinnon CM, Docherty K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. <i>Diabetologia<\/i>, <b>44<\/b>, 1203\u20131214 (2001).","DOI":"10.1007\/s001250100628"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Furukawa N, Shirotani T, Araki E, Kaneko K, Todaka M, Matsumoto K, Tsuruzoe K, Motoshima H, Yoshizato K, Kishikawa H, Shichiri M. Possible involvement of atypical protein kinase C (PKC) in glucose-sensitive expression of the human insulin gene: DNA-binding activity and transcriptional activity of pancreatic and duodenal homeobox gene-1 (PDX-1) are enhanced <i>via<\/i> calphostin C-sensitive but phorbol 12-myristate 13-acetate (PMA) and G\u00f6 6976-insensitive pathway. <i>Endocr. J<\/i>., <b>46<\/b>, 43\u201358 (1999).","DOI":"10.1507\/endocrj.46.43"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Miggin SM, O\u2019Neill LAJ. New insights into the regulation of TLR signaling. <i>J. Leukoc. Biol<\/i>., <b>80<\/b>, 220\u2013226 (2006).","DOI":"10.1189\/jlb.1105672"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. <i>Nat. Rev. Drug Discov<\/i>., <b>8<\/b>, 627\u2013644 (2009).","DOI":"10.1038\/nrd2926"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Miele C, Raciti GA, Cassese A, Romano C, Giacco F, Oriente F, Paturzo F, Andreozzi F, Zabatta A, Troncone G, Bosch F, Pujol A, Chneiweiss H, Formisano P, Beguinot F. PED\/PEA-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic \u03b2-cells. <i>Diabetes<\/i>, <b>56<\/b>, 622\u2013633 (2007).","DOI":"10.2337\/db06-1260"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen C-S, Newton AC, Schaffhausen BS, Toker A. Regulation of protein kinase C \u03b6 by PI 3-kinase and PDK-1. <i>Curr. Biol<\/i>., <b>8<\/b>, 1069\u20131077 (1998).","DOI":"10.1016\/S0960-9822(98)70444-0"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/1\/48_b24-00582\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:29:25Z","timestamp":1738380565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/1\/48_b24-00582\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00582","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"article-number":"b24-00582"}}